Skip to main navigation Skip to search Skip to main content

Amgen: EVOLVE MI A Pragmatic Randomized Multicenter Trial of Evolocumab Administered Very Early to Reduce the Risk of Cardiovascular Events in Patients Hospitalized with Acute Myocardial Infarction

Project: Research

Project Details

StatusActive
Effective start/end date12/1/2305/17/27

Funding

  • Colorado Prevention Center: $84,340.50